Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study
Clinical trial NCT03918629 · COMPLETED
Trial details
- NCT number
- NCT03918629
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-12-22
- Enrollment
- 1994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.